Random 42 is the global market leader in the provision of medical animation and digital media services to the healthcare and pharmaceutical industry. Its core capabilities include 2D and 3D animation, interactive services, mobile applications and website design.
Its talented animation artists, along with an experienced management team with qualifications in biology, genetics and illustration/graphic design, are able to offer a bespoke product to suit each individual clients’ requirements.
Random 42 has worked with 23 of the top 25 pharmaceutical companies worldwide and has won over 100 industry awards.
Bank debt has been provided by HSBC.
"Vespa Capital quickly understood the opportunities and challenges the business currently faces and we are delighted to partner with such a constructive, experienced and helpful firm. We look forward to working with them at this exciting stage of Random42’s life."
Ben Ramsbottom, CEO, Random 42
“Random42's unique strengths of scientific understanding, leading edge animation and first rate process management have enabled it to become the leading provider of animation sequences for the pharmaceutical industry. With more investment in customer support and utilising the latest technology the business is well positioned to continue its strong growth track and we look forward to working with Ben and his team.”
Nigel Hammond, Partner, Vespa Capital